These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37436157)

  • 21. Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students.
    Fu H; Chen Z; Teng W; Du Z; Zhang Y; Ye X; Yu Z; Zhang Y; Pi X
    Microbiol Res; 2024 Aug; 285():127741. PubMed ID: 38761487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii.
    Li R; Wan X; Takala TM; Saris PEJ
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):229-237. PubMed ID: 32567021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
    J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Briand F; Sulpice T; Giammarinaro P; Roux X
    Benef Microbes; 2019 May; 10(5):555-567. PubMed ID: 31090460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.
    Cárdenas PA; Garcés D; Prado-Vivar B; Flores N; Fornasini M; Cohen H; Salvador I; Cargua O; Baldeón ME
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1365-1372. PubMed ID: 32125555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?
    Cui B; Lin L; Wang B; Liu W; Sun C
    Pharmacol Res; 2022 Jan; 175():106022. PubMed ID: 34883213
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Gao H; Li Y; Xu J; Zuo X; Yue T; Xu H; Sun J; Wang M; Ye T; Yu Y; Yao Y
    Front Microbiol; 2023; 14():1204122. PubMed ID: 37492256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
    Hedin KA; Rees VE; Zhang H; Kruse V; Vazquez-Uribe R; Sommer MOA
    Sci Rep; 2022 May; 12(1):8862. PubMed ID: 35614092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
    Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
    PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Tunable and Expandable Transactivation System in Probiotic Yeast
    Kwak S; Mahmud B; Dantas G
    ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
    Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
    Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 33. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
    Liu CH; Chang JH; Chang YC; Mou KY
    J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saccharomyces boulardii (CNCM I-745) alleviates collagen-induced arthritis by partially maintaining intestinal mucosal integrity through TLR2/MYD88/NF-κB pathway inhibition.
    Ahmad ; Zhang C; Wang Y; Ullah H; Rahman AU; Wei J; Qin YH; Wang G; Wang B; Li X
    Int Immunopharmacol; 2024 Sep; 139():112738. PubMed ID: 39053232
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Pais P; Almeida V; Yılmaz M; Teixeira MC
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32512834
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.
    Hudson LE; McDermott CD; Stewart TP; Hudson WH; Rios D; Fasken MB; Corbett AH; Lamb TJ
    PLoS One; 2016; 11(4):e0153351. PubMed ID: 27064405
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Li B; Zhang H; Shi L; Li R; Luo Y; Deng Y; Li S; Li R; Liu Z
    Food Funct; 2022 Jan; 13(1):102-112. PubMed ID: 34878454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saccharomyces boulardii promoters for control of gene expression in vivo.
    Sands C; Hedin KA; Vazquez-Uribe R; Sommer MOA
    Microb Cell Fact; 2024 Jan; 23(1):16. PubMed ID: 38185666
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Albuquerque RCMF; Brandão ABP; De Abreu ICME; Ferreira FG; Santos LB; Moreira LN; Taddei CR; Aimbire F; Cunha TS
    Benef Microbes; 2019 Dec; 10(8):901-912. PubMed ID: 31965836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.